FOX 47 - Health News
The Food and Drug Administration is on the verge of approving a new cancer vaccine.
In clinical trials, the vaccine helped prostate cancer patients live longer without the harsh side effects of chemo and radiation.
Doctors are quick to point out it's a vaccine only in name -- it's not preventative, it's not a cure -- but it may offer some hope.
Seattle-based Dendreon Corp. has developed a new cancer treatment -- a revolutionary cancer vaccine.
During treatment, doctors draw blood from a cancer patient, train the white blood cells to attack cancer cells, and inject them back into the body.
"This is a therapy targeting the immune system and then has your immune system target the cancer," said Dr. George Wilding, director of the UW Carbon Cancer Center.
Dr. Wilding says the UW served as one of the clinical trial locations for the vaccine. He says, unlike chemo, the vaccine does not destroy good cells in the body.
"This is entirely different that what has been used before," he said.
Studies show prostate cancer patients who took the vaccine lived, on average 4.5 months longer. Some men gained an extra two or three years of life.
"This would be a way to give hope to those people for whom other treatment options either wouldn't work or had not resulted in a cure," said Dr. D. Brooke Johnson, a urologist with Dean Health & St. Mary's Hospital.
Dr. Johnson says the vaccine is promising, but for most patients, it won't replace surgery, radiation, and chemotherapy. At least, he says, it's another option.
"It's a little too early to say if this will have long-term benefits for the general population with prostate cancer," he said.
So far, the only side effects of the vaccine are fevers and chills experienced by a few patients.
Doctors hope research with this prostate cancer vaccine will eventually help create vaccines for many kinds of cancers.
Prostate cancer kills about 30,000 men in United States every year.
Sun. - Fri. on FOX 47 News at 9!
Top Health Headlines (foxnews.com)
|AstraZeneca taps Roche, Qiagen for new blood-based cancer drug tests|
AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs
|On dates with men, nice girls finish first|
Men really do prefer "nice gals," but men have more leeway when it comes to attracting women, a new study finds
|Kids with pets more likely to avoid eating meat|
Kids who spend time cuddling up with Fido or Fluffy are more likely to turn their noses up at meat later in life, a new study suggests
|New glaucoma treatment approved|
Swiss pharmaceutical group Novartis said the European Commission has approved its eyecare unit Alcon's Simbrinza treatment for glaucoma, a chronic, sight-threatening eye disease
|The ubiquitous choking poster gets a makeover|
Restaurants in New York City are replacing the official notices with hand-crafted alternatives
Tonight on FOX 47
5:00pm Two and a Half Men
5:30pm Big Bang Theory
6:00pm Modern Family
6:30pm Big Bang Theory
8:00pm Hotel Hell
9:00pm FOX 47 News at 9
9:35pm Modern Family
10:05pm Two and a Half Men
10:35pm Everybody Loves Raymond
11:05pm The Arsenio Hall Show